相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。p16INK4A inhibits the pro-metastatic potentials of osteosarcoma cells through targeting the ERK pathway and TGF-1
Gabriela Silva et al.
MOLECULAR CARCINOGENESIS (2016)
A murine model for the development of melanocytic nevi and their progression to melanoma
Tahseen H. Nasti et al.
MOLECULAR CARCINOGENESIS (2016)
Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts
Woan-Ruoh Lee et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Altered Glucose Metabolism in Harvey-ras Transformed MCF10A Cells
Wei Zheng et al.
MOLECULAR CARCINOGENESIS (2015)
CRKL promotes lung cancer cell invasion through ERK-MMP9 pathway
Fu Lin et al.
MOLECULAR CARCINOGENESIS (2015)
Overexpression of DNAJB6 Promotes Colorectal Cancer Cell Invasion Through an IQGAP1/ERK-Dependent Signaling Pathway
Tong-Tong Zhang et al.
MOLECULAR CARCINOGENESIS (2015)
A Subset of Papillary Thyroid Carcinomas Contain KRAS Mutant Subpopulations at Levels Above Normal Thyroid
Meagan B. Myers et al.
MOLECULAR CARCINOGENESIS (2014)
The Role of ERK2 in Colorectal Carcinogenesis Is Partly Regulated by TRAPPC4
Yu-Rong Weng et al.
MOLECULAR CARCINOGENESIS (2014)
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells By Reactivating MEK and ERK Signaling
Berta Sanchez-Laorden et al.
SCIENCE SIGNALING (2014)
MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
Nikhil Wagle et al.
CANCER DISCOVERY (2014)
CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression
Ming-Chung Jiang et al.
AMERICAN JOURNAL OF SURGERY (2013)
BRAFV600E protein expression and outcome from BRAF inhibitor treatment in BRAFV600E metastatic melanoma
J. S. Wilmott et al.
BRITISH JOURNAL OF CANCER (2013)
A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway
Christian Praetorius et al.
CELL (2013)
MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function
Christine Grill et al.
HUMAN MOLECULAR GENETICS (2013)
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Anna A. Brozyna et al.
HUMAN PATHOLOGY (2013)
Correlations between cytoplasmic CSE1L in neoplastic colorectal glands and depth of tumor penetration and cancer stage
Cheng-Jeng Tai et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Ras-induced melanoma transformation is associated with the proteasomal degradation of the transcriptional repressor ICER
Marlene Healey et al.
MOLECULAR CARCINOGENESIS (2013)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
Targeting RAF-MEK-ERK kinase-scaffold interactions in cancer
Darrin D. Stuart et al.
NATURE MEDICINE (2013)
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
Patrick A. Oberholzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Mutational analysis of cutaneous squamous cell carcinomas and verrucal keratosis in patients taking BRAF inhibitors
Rachael Anforth et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
The Role of Alpha-Synuclein in Melanin Synthesis in Melanoma and Dopaminergic Neuronal Cells
Tianhong Pan et al.
PLOS ONE (2012)
ERK1/2 MAP kinases: Structure, function, and regulation
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2012)
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
Satoru Yokoyama et al.
NATURE (2011)
Transcriptional control of melanoma metastasis: The importance of the tumor microenvironment
Russell R. Braeuer et al.
SEMINARS IN CANCER BIOLOGY (2011)
Cellular apoptosis susceptibility (CSE1L/CAS) protein in cancer metastasis and chemotherapeutic drug-induced apoptosis
Cheng-Jeng Tai et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Main roads to melanoma
Giuseppe Palmieri et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
Francisco Solano et al.
PIGMENT CELL RESEARCH (2006)
Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB
Bidisha Saha et al.
PIGMENT CELL RESEARCH (2006)
Melanogenesis and evidence for melanosome transport to the plasma membrane in a CD83+ teleost leukocyte cell line
Erlend Haugarvoll et al.
PIGMENT CELL RESEARCH (2006)
MITF: master regulator of melanocyte development and melanoma oncogene
Carmit Levy et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation
DM Molina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
LA Garraway et al.
NATURE (2005)
Phosphodiesterase inhibitors stimulate osteoclast formation via TRANCE/RANKL expression in osteoblasts: possible involvement of ERK and p38 MAPK pathways
M Takami et al.
FEBS LETTERS (2005)
The transcription network regulating melanocyte development and melanoma
KW Vance et al.
PIGMENT CELL RESEARCH (2004)
Sphingosine-1-phosphate decreases melanin synthesis via sustained ERK activation and subsequent MITF degradation
DS Kim et al.
JOURNAL OF CELL SCIENCE (2003)
Differentiation therapy of human cancer: basic science and clinical applications
M Leszczyniecka et al.
PHARMACOLOGY & THERAPEUTICS (2001)
A Ras by any other name
D Bar-Sagi
MOLECULAR AND CELLULAR BIOLOGY (2001)
Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway
SS Grewal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
